activity
20182026
most citedRUDDER: Return Decomposition for Delayed Rewards

105 citations · 203 across the 6 of their papers we have counts for

collaborators

8 papers

cs.LG2026

Critical Mass: Structure-Disjoint Splits Drift With the Libraries They Are Built On

Tomo Oga, Devesh Shah, Cailum M. K. Stienstra +4

Molecular machine learning evaluates out-of-distribution performance with structure disjoint splits, a construction rule fixed once at the scale its library happened to have: thres…

cs.LG2025

Attribution assignment for deep-generative sequence models enables interpretability analysis using positive-only data

Robert Frank, Michael Widrich, Rahmad Akbar +4

Generative machine learning models offer a powerful framework for therapeutic design by efficiently exploring large spaces of biological sequences enriched for desirable properties…

cs.LG2020★ 24 cited

Cross-Domain Few-Shot Learning by Representation Fusion

Thomas Adler, Johannes Brandstetter, Michael Widrich +5

In order to quickly adapt to new data, few-shot learning aims at learning from few examples, often by using already acquired knowledge. The new data often differs from the previous…

hep-th2020

A physical protocol for observers near the boundary to obtain bulk information in quantum gravity

Chandramouli Chowdhury, Olga Papadoulaki, Suvrat Raju

We consider a set of observers who live near the boundary of global AdS, and are allowed to act only with simple low-energy unitaries and make measurements in a small interval of t…

cs.LG2020

Modern Hopfield Networks and Attention for Immune Repertoire Classification

Michael Widrich, Bernhard Schäfl, Hubert Ramsauer +8

A central mechanism in machine learning is to identify, store, and recognize patterns. How to learn, access, and retrieve such patterns is crucial in Hopfield networks and the more…

q-bio.BM2020

Large-scale ligand-based virtual screening for SARS-CoV-2 inhibitors using deep neural networks

Markus Hofmarcher, Andreas Mayr, Elisabeth Rumetshofer +8

Due to the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, there is an urgent need for novel therapies and drugs. We conducted a large-scale virtual…